Hematopoietic Stem Cell Transplantation Clinical Trials in Wuhan, Hubei
6 recruitingWuhan, Hubei, China
Showing 1–6 of 6 trials
Recruiting
Phase 2
Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Acute Graft Versus Host DiseaseGraft-Versus-Host DiseaseALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology42 enrolled1 locationNCT07572669
Recruiting
Phase 4
Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.
Graft vs Host DiseaseHematopoietic Stem Cell TransplantationCytomegalovirus Infections+1 more
WeiShi120 enrolled1 locationNCT07569653
Recruiting
Phase 3
Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial
VenentoclaxALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONMyeloid Malignancies+3 more
First Affiliated Hospital of Zhejiang University186 enrolled18 locationsNCT07396480
Recruiting
Not Applicable
Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT
PreventionHematopoietic Stem Cell TransplantationHemorrhagic Cystitis+1 more
Yi Zhang266 enrolled4 locationsNCT06198517
Recruiting
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cell TransplantationCardiovascular EventsTransplant Complication
Peking University People's Hospital10,000 enrolled16 locationsNCT07349498
Recruiting
Not Applicable
Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT
TreatmentHematopoietic Stem Cell TransplantationHemorrhagic Cystitis+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology60 enrolled1 locationNCT06241274